Retatrutide 60mg
Maximum Bulk — The Most Advanced Compound at Scale
The maximum bulk format for retatrutide — lowest cost per milligram available, designed for serious long-term research at the frontier of fat loss pharmacology.
Starting From
$589.99
Sold By
Apollo Peptide Sciences
Suggested Protocol
Exclusively for experienced researchers at confirmed 8–12mg weekly maintenance dose. Reconstitute with 4–6ml bacteriostatic water for precise working concentrations. SubQ injection once weekly. Store reconstituted vial refrigerated; draw from the single vial across consecutive weeks. Maintain strict cold chain — do not allow the reconstituted vial to reach room temperature between uses.
24.2%
Body Wt. Loss
5–7.5 wks
Duration
Max 60 mg
Format
The Full Scale of the Most Advanced Compound in Fat Loss Research
Retatrutide 60mg is the pinnacle of the Apollo weight management lineup — the maximum bulk format for the most pharmacologically advanced fat loss compound in research, carrying the lowest cost per milligram across all retatrutide vial sizes. It is the supply format for researchers who have moved beyond exploration and are executing sustained, long-term protocols with the compound that produced the highest documented fat loss outcomes in peer-reviewed clinical history.
At 8–12mg weekly maintenance dosing, a single 60mg vial provides five to seven and a half weeks of uninterrupted research supply — a meaningful protocol block that enables proper assessment of retatrutide's cumulative effects on body composition, hepatic fat, visceral adiposity, and metabolic markers. The Phase 2 NEJM data documenting 24.2% average body weight reduction was generated over 48 weeks of sustained dosing; protocols of that ambition demand bulk supply logistics.
Retatrutide's glucagon receptor component is what separates it categorically from semaglutide and tirzepatide. Glucagon receptor agonism creates active, continuous fat oxidation pressure between weekly doses — the liver is signaled to mobilize stored fat even in the absence of the caloric deficit that GLP-1 compounds depend on to work. Over weeks and months, this third mechanism produces visceral fat and hepatic fat reductions that exceed what appetite suppression alone can achieve. The 60mg vial exists to supply the duration required for this mechanism to fully express itself.
For the serious long-term retatrutide researcher, the per-milligram cost at the 60mg tier versus repeated purchases of smaller vials is the strongest financial argument in the catalog. The compound itself represents the frontier of fat loss pharmacology; the 60mg vial ensures you can pursue that frontier without operational constraints.
Protocol Design at This Level
5–7.5 Weeks From a Single Vial: How to Structure Long-Duration Retatrutide Research
At 8mg weekly, a reconstituted 60mg vial provides 7.5 weeks of uninterrupted supply. At 12mg weekly, 5 weeks. Both durations are meaningful blocks of sustained maintenance-phase research — long enough to observe measurable changes in body composition, hepatic fat, and metabolic markers. Structuring these 5–7.5 week blocks with consistent assessment at start, midpoint, and end creates the kind of systematic data that serious researchers need to evaluate the compound's effects on their specific physiology. The 60mg vial enables this structure without supply anxiety.
Why Continuity Matters Most With Retatrutide
Triple Agonism Depends on Sustained Signal — and Protocol Gaps Disrupt All Three Mechanisms
With semaglutide, a one-week gap is suboptimal but recoverable — the compound's 7-day half-life means plasma levels don't crash immediately. Retatrutide's triple mechanism means a dosing gap simultaneously disrupts GLP-1 receptor engagement (appetite returns), GIP receptor signaling (insulin sensitivity partially reverts), and glucagon receptor activation (active fat oxidation pressure drops). The result of a multi-day gap is a more complete return to the pre-protocol metabolic state than with simpler compounds. The 60mg vial eliminates supply gaps as a variable entirely — which for the most mechanistically complex fat loss compound available, is precisely the point.
The Economics of Frontier Research
What the Lowest Per-Milligram Cost Means for a Protocol Built on the Best Data in Obesity Pharmacology
Retatrutide's 24.2% body weight reduction Phase 2 data represents the strongest documented fat loss outcome in peer-reviewed clinical history to date. The 60mg vial at the lowest per-milligram cost is the supply format that makes sustained engagement with the most advanced compound financially rational. Over a 6-month protocol at 10mg weekly (approximately 260mg total), the per-milligram difference between 60mg bulk pricing and repeated 15mg or 30mg purchases compounds into a meaningful cost difference. For researchers committed to the frontier of fat loss pharmacology, the 60mg vial is both the most economical and the most serious supply format available.
Key Benefits
Lowest cost per milligram of any retatrutide format in the Apollo catalog
Provides 5–7.5 weeks of supply at 8–12mg weekly maintenance dosing
Supports the extended protocol duration required for full glucagon-mediated effects
Eliminates supply gaps that interrupt retatrutide's cumulative metabolic impact
The scale-appropriate format for protocols modeled on 48-week Phase 2 research design
Minimum reordering burden for researchers committed to long-term protocols
Best economics for multi-month retatrutide research programs
The most advanced compound in research, at the most efficient supply scale
Full Protocol
Exclusively for experienced researchers at confirmed 8–12mg weekly maintenance dose. Reconstitute with 4–6ml bacteriostatic water for precise working concentrations. SubQ injection once weekly. Store reconstituted vial refrigerated; draw from the single vial across consecutive weeks. Maintain strict cold chain — do not allow the reconstituted vial to reach room temperature between uses.
Best Stacked With
More in Weight Management
View All
Semaglutide
The compound behind Ozempic/Wegovy. GLP-1 receptor agonist producing significant appetite suppression, fat loss, and metabolic improvement with once-weekly dosing.
